OpenAI unveils GPT-Rosalind to accelerate drug discovery for pharma giants
New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences
New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences
The company maintained a competitive ARPOB while steadily improving occupancy, driven by higher patient volumes and efficient capacity utilization
Venus Remedies secures marketing authorization in Philippines
The company operates four mid-sized hospitals with a total bed capacity of 556 in eastern India
As of December 31, 2025, the company reported total cash, cash equivalents and short-term investments of approximately $4.94 million
The goal is to deliver greater value to customers, doctors, and the broader healthcare ecosystem
The system, called GeneAgent, cross-checks its own initial predictions for accuracy against information from established, expert-curated databases
Bringing a new drug to market takes about 10 years and requires an investment of approximately $1 billion
The workshop aimed to equip medicos with the necessary skills & knowledge to leverage AI's transformative power
Subscribe To Our Newsletter & Stay Updated